4
2
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T22318 |
Taletrectinib
DS-6051b,AB-106 |
Trk receptor; ROS; ROS Kinase | Immunology/Inflammation; Tyrosine Kinase/Adaptors |
Taletrectinib (AB-106) 是具有口服活力的、选择性的 ROS1/NTRK 抑制剂。它对重组 ROS1、NTRK1、NTRK2 和 NTRK3 有较强的抑制作用,IC50值分别为 0.207、0.622、2.28 和 0.98 nM。它还抑制 ROS1 G2032R 和其他抗 Crizotinib 的 ROS1 突变体。 | |||
T38995 |
Taletrectinib free base
AB-106freebase,Taletrectinib free base,IBI-344 free base,DS-6051b free base |
ROS Kinase | Tyrosine Kinase/Adaptors |
Taletrectinib free base (AB-106 free base) 是一种新型有效且具有选择性和口服活性的 ROS1/NTRK 抑制剂。Taletrectinib free base 对重组 ROS1、NTRK1、NTRK2 和 NTRK3 具有较强的抑制作用, IC50分别以0.207、0.622、2.28 和 0.98 nM。Taletrectinib free base还对 ROS1 G2032R 和其他抗 Crizotinib 的 ROS1 突变有抑制作用。 | |||
T62531 |
TRK-IN-12
|
||
TRK-IN-12 (Compound 9e) 是一种大环衍生的有效TRK抑制剂,具有显著的TRKG595R抑制活性 (IC50= 13.1 nM)。在Ba/F3-LMNA-NTRK1细胞系中具有出色的抗增殖效果 (IC50= 0.080 μM),并且在Ba/F3-LMNA-NTRK1-G595R细胞系中展示了超过对照活性分子LOXO-101的抑制能力 (IC50= 0.646 μM)。 | |||
T79706 |
TRK-IN-24
|
Trk receptor | Tyrosine Kinase/Adaptors |
TRK-IN-24(compound 10g)是一种针对Trk Receptor的抑制剂,它对TRKA、TRKC、TRKAG595R、TRKAG667C和TRKAF589L的抑制作用的IC50值分别达到5.21、4.51、6.77、1.42和6.13 nM。该化合物在BaF3-CD74-NTRK1G595R和BaF3-CD74-NTRK1G667C异种移植模型中显示出明显的抗肿瘤活性。此外,TRK-IN-24 能有效抑制携带SF、GK、xDFG等单点突变的Ba/F3细胞增殖,其IC50范围为1.43至47.56 nM。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPK-00774 |
TrkA Protein, Human, Recombinant (aa 33-417, His)
TrkAI,TrkA I,Trk-A,TRKA,NTRK1,MTC,TRK,TrkA... |
Human | HEK293 Cells |
TrkA, a tyrosine kinase receptor, is an essential component of the nerve growth factor (NGF) response pathway. The binding of NGF to the receptor induces receptor autophosphorylation and activation of intracellular signaling pathways, resulting in diverse biological effects. | |||
TMPH-02878 |
PTPRS Protein, Mouse, Recombinant (His & Myc)
|
Mouse | E. coli |
Cell surface receptor that binds to glycosaminoglycans, including chondroitin sulfate proteoglycans and heparan sulfate proteoglycans. Binding to chondroitin sulfate and heparan sulfate proteoglycans has opposite effects on PTPRS oligomerization and regulation of neurite outgrowth. Contributes to the inhibition of neurite and axonal outgrowth by chondroitin sulfate proteoglycans, also after nerve transection. Plays a role in stimulating neurite outgrowth in response to the heparan sulfate proteo... |